Cargando…
ERα, A Key Target for Cancer Therapy: A Review
Estrogen receptor α (ERα) is closely associated with both hormone-dependent and hormone-independent tumors, and it is also essential for the development of these cancers. The functions of ERα are bi-faceted; it can contribute to cancer progression as well as cancer inhibition. Therefore, understandi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073439/ https://www.ncbi.nlm.nih.gov/pubmed/32210584 http://dx.doi.org/10.2147/OTT.S236532 |
_version_ | 1783506619966947328 |
---|---|
author | Liu, Yanfang Ma, Hong Yao, Jing |
author_facet | Liu, Yanfang Ma, Hong Yao, Jing |
author_sort | Liu, Yanfang |
collection | PubMed |
description | Estrogen receptor α (ERα) is closely associated with both hormone-dependent and hormone-independent tumors, and it is also essential for the development of these cancers. The functions of ERα are bi-faceted; it can contribute to cancer progression as well as cancer inhibition. Therefore, understanding ERα is vital for the treatment of those cancers that are closely associated with its expression. Here, we will elaborate on ERα based on its structure, localization, activation, modification, and mutation. Also, we will look at co-activators of ERα, elucidate the signaling pathway activated by ERα, and identify cancers related to its activation. A comprehensive understanding of ERα could help us to find new ways to treat cancers. |
format | Online Article Text |
id | pubmed-7073439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-70734392020-03-24 ERα, A Key Target for Cancer Therapy: A Review Liu, Yanfang Ma, Hong Yao, Jing Onco Targets Ther Review Estrogen receptor α (ERα) is closely associated with both hormone-dependent and hormone-independent tumors, and it is also essential for the development of these cancers. The functions of ERα are bi-faceted; it can contribute to cancer progression as well as cancer inhibition. Therefore, understanding ERα is vital for the treatment of those cancers that are closely associated with its expression. Here, we will elaborate on ERα based on its structure, localization, activation, modification, and mutation. Also, we will look at co-activators of ERα, elucidate the signaling pathway activated by ERα, and identify cancers related to its activation. A comprehensive understanding of ERα could help us to find new ways to treat cancers. Dove 2020-03-11 /pmc/articles/PMC7073439/ /pubmed/32210584 http://dx.doi.org/10.2147/OTT.S236532 Text en © 2020 Liu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Liu, Yanfang Ma, Hong Yao, Jing ERα, A Key Target for Cancer Therapy: A Review |
title | ERα, A Key Target for Cancer Therapy: A Review |
title_full | ERα, A Key Target for Cancer Therapy: A Review |
title_fullStr | ERα, A Key Target for Cancer Therapy: A Review |
title_full_unstemmed | ERα, A Key Target for Cancer Therapy: A Review |
title_short | ERα, A Key Target for Cancer Therapy: A Review |
title_sort | erα, a key target for cancer therapy: a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073439/ https://www.ncbi.nlm.nih.gov/pubmed/32210584 http://dx.doi.org/10.2147/OTT.S236532 |
work_keys_str_mv | AT liuyanfang eraakeytargetforcancertherapyareview AT mahong eraakeytargetforcancertherapyareview AT yaojing eraakeytargetforcancertherapyareview |